Deals & business · 4h ago Alphabet and Meta now spend nearly as much on R&D as pharma’s 10 largest drugmakers 1 outlet Johnson & Johnson Roche
Trials & R&D · 11h ago J&J says analysis demonstrates potential of Tecvayli-Darzalex combo for multiple myeloma 2 outlets Johnson & Johnson
Pricing & policy · 13h ago What J&J’s Spravato patent win could mean for psychedelic drugs 1 outlet Johnson & Johnson
Deals & business · 22h ago Growth mode: 3 biotechs that are staffing up after series B raises 1 outlet Eli Lilly Johnson & Johnson
